AAN 2023
75th American Academy of Neurology Annual Meeting
April 22-27, 2023 | Boston, US
Ravulizumab improves post-intervention status in AChR Ab+ gMG patients: A prespecified exploratory analysis of the CHAMPION MG study
Continuous ofatumumab treatment in RMS incurs lower disability and brain volume loss: The 5-year update of ASCLEPIOS I/II and ALITHIOS
Machine learning predicts post-ischemic stroke seizure determinants
Long-term efgartigimod for gMG is efficacious and well-tolerated: The ADAPT+ open-label extension study
Oral ozanimod treatment demonstrates long-term efficacy in improving CPS of RMS patients: The phase 3 SUNBEAM and DAYBREAK open-label extension studies
Nusinersen shows functional improvement and good tolerability in adults with type II/III SMA at month 14: Interim analysis of the SAS trial
Rimegepant showed benefits for acute treatment and prevention of migraine in adult women - a post-hoc analysis
Non-pharmacological management improves the quality of care for dementia patients and reduces significant stress on caregivers